Andere Sprachen Valeo Pharma Inc.

Aktien

A2PLB4

CA91915B1085

VPH

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:59:59 28.06.2024			% 5 Tage	% 1. Jan.
0.105 ^CAD	-8.70%		-4.55%	-41.67%

18.06.	Valeo Pharma ernennt Chief Development Officer; Anstieg um fast 22%	MT
18.06.	Valeo Pharma Inc. ernennt Al Moghaddam zum Chief Development Officer und scheidet folglich aus dem Verwaltungsrat aus	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Valeo Pharma Names Chief Development Officer; Up Nearly 22%	18.06.
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE	18.06.
Valeo Pharma Inc. Appoints Al Moghaddam as Chief Development Officer and Consequently Steps Down from its Board of Directors	18.06.
Valeo Pharma hits record 2nd quarter revenue as demand for Asthma products continues to rise	17.06.
Valeo Pharma Fiscal Q2 Loss Widens 21% as Expenses Increase; Revenue Up 4%	14.06.
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES	13.06.
Valeo Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	13.06.
Toronto Stocks Retreat; ADF Group Shares Fall on C$47.9 Million Buyback from Certain Board Members	13.06.
Valeo Pharma Restructures Commercial Field Operations to Lower Expenses	13.06.
Valeo Pharma Announces Restructuring of Commercial Field Operations to Support Path to Profitability	13.06.
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY	13.06.
VALEO PHARMA TO HOST SECOND QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST	04.06.
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS	25.04.
VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE	09.04.
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS	25.03.
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS	22.03.
Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors	22.03.
VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS	14.03.
Valeo Pharma Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	14.03.
VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL, WEBCAST	08.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Valeo Pharma Inc.

Aktien

A2PLB4

CA91915B1085

VPH

Andere Sprachen

Filter